Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PRVA
stocks logo

PRVA

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
513.98M
+11.52%
0.029
-2.63%
543.79M
+13.27%
0.060
+101.03%
567.68M
+8.93%
0.074
+268.2%
Estimates Revision
The market is revising Upward the revenue expectations for Privia Health Group, Inc. (PRVA) for FY2025, with the revenue forecasts being adjusted by 4.41% over the past three months. During the same period, the stock price has changed by 3.09%.
Revenue Estimates for FY2025
Revise Upward
up Image
+4.41%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-17.4%
In Past 3 Month
Stock Price
Go Up
up Image
+3.09%
In Past 3 Month
Wall Street analysts forecast PRVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRVA is 30.71 USD with a low forecast of 23.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
Wall Street analysts forecast PRVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRVA is 30.71 USD with a low forecast of 23.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
2 Hold
0 Sell
Strong Buy
Current: 24.000
sliders
Low
23.00
Averages
30.71
High
35.00
Current: 24.000
sliders
Low
23.00
Averages
30.71
High
35.00
JPMorgan
Lisa Gill
maintain
$32 -> $33
2025-11-13
Reason
JPMorgan
Lisa Gill
Price Target
$32 -> $33
2025-11-13
maintain
Reason
JPMorgan analyst Lisa Gill raised the firm's price target on Privia Health to $33 from $32 and keeps an Overweight rating on the shares. The firm updated the company's estimates post earnings.
Canaccord
Buy
maintain
$32 -> $34
2025-11-12
Reason
Canaccord
Price Target
$32 -> $34
2025-11-12
maintain
Buy
Reason
Canaccord raised the firm's price target on Privia Health to $34 from $32 and keeps a Buy rating on the shares. The firm said its thesis on the copany is playing out as the Q3 beat was strong across the board and management noted that 3Q capitated results would likely be the high-water mark for 2025 as there was retroactive timing of data that contributed to the strength.
BMO Capital
Sean Dodge
Outperform
initiated
$30
2025-11-12
Reason
BMO Capital
Sean Dodge
Price Target
$30
2025-11-12
initiated
Outperform
Reason
BMO Capital analyst Sean Dodge initiated coverage of Privia Health with an Outperform rating and $30 price target. The firm sees Privia as a "stable long-term earnings compounder with impressive" free cash flow. The stock offers one of the best ways to gain exposure to value-based care given the company's highly recurring revenue and expansion opportunities, the analyst tells investors in a research note.
Barclays
Andrew Mok
Equal Weight
maintain
$22 -> $23
2025-11-10
Reason
Barclays
Andrew Mok
Price Target
$22 -> $23
2025-11-10
maintain
Equal Weight
Reason
Barclays analyst Andrew Mok raised the firm's price target on Privia Health to $23 from $22 and keeps an Equal Weight rating on the shares post the Q3 report. The company's "prudence" in accruing performance in capitated contracts and shared savings began to pay off, the analyst tells investors in a research note.
Evercore ISI
Outperform
maintain
$28 -> $30
2025-11-07
Reason
Evercore ISI
Price Target
$28 -> $30
2025-11-07
maintain
Outperform
Reason
Evercore ISI raised the firm's price target on Privia Health to $30 from $28 and keeps an Outperform rating on the shares. The company's execution track record merits a premium valuation, the analyst tells investors.
Citizens JMP
Outperform
maintain
$30 -> $31
2025-11-07
Reason
Citizens JMP
Price Target
$30 -> $31
2025-11-07
maintain
Outperform
Reason
Citizens JMP raised the firm's price target on Privia Health to $31 from $30 and keeps an Outperform rating on the shares. Privia Health fired on all cylinders in Q3, with most key operating and financial metrics exceeding expectations, the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Privia Health Group Inc (PRVA.O) is 92.84, compared to its 5-year average forward P/E of 47.01. For a more detailed relative valuation and DCF analysis to assess Privia Health Group Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
47.01
Current PE
92.84
Overvalued PE
348.36
Undervalued PE
-254.34

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
37.09
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
58.01
Undervalued EV/EBITDA
16.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.95
Current PS
0.00
Overvalued PS
2.84
Undervalued PS
1.06
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 431.38% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

PRVA News & Events

Events Timeline

(ET)
2025-11-06
06:16:41
Privia Health increases FY25 revenue forecast to $2.05B-$2.1B, up from $1.8B-$1.9B
select
2025-11-06
06:14:42
Privia Health announces Q3 adjusted earnings per share of 29 cents, surpassing consensus estimate of 22 cents.
select
2025-09-23 (ET)
2025-09-23
16:18:13
Privia Health to Purchase ACO Division from Evolent Health for $100 Million in Cash
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
11-13Benzinga
BMO Capital Begins Coverage of Privia Health Group with Outperform Rating and Sets Price Target at $30

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, helping them stay informed and make timely decisions in the stock market.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters, enhancing the trading experience for its users.

  • Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, indicating a robust network for sharing market intelligence.

  • Market Winning Tools: Benzinga Pro is designed to equip traders with the tools and information necessary to succeed in the markets daily.

[object Object]
Preview
6.0
11-07Benzinga
Evercore ISI Group Reaffirms Outperform Rating for Privia Health Group, Increases Price Target to $30

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, providing real-time market intelligence to help them succeed.

  • Exclusive Content: Subscribers gain access to exclusive stories and insights generated by Benzinga reporters, enhancing their trading strategies.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing knowledge and strategies for better trading outcomes.

  • Market Winning Tools: The platform is designed to equip traders with the tools and information necessary to make informed decisions in the stock market.

[object Object]
Preview
9.5
11-06Yahoo Finance
Privia Health: Overview of Q3 Earnings

  • Quarterly Profit Report: Privia Health Group Inc. reported a third-quarter profit of $6.9 million, equating to 5 cents per share.

  • Earnings vs. Expectations: The earnings fell short of Wall Street expectations, which anticipated earnings of 6 cents per share.

  • Revenue Performance: The company posted revenue of $580.4 million, exceeding analyst forecasts of $497.6 million.

  • Full-Year Revenue Outlook: Privia Health expects its full-year revenue to be between $2.05 billion and $2.1 billion.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Privia Health Group Inc (PRVA) stock price today?

The current price of PRVA is 24 USD — it has decreased -1.23 % in the last trading day.

arrow icon

What is Privia Health Group Inc (PRVA)'s business?

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

arrow icon

What is the price predicton of PRVA Stock?

Wall Street analysts forecast PRVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRVA is 30.71 USD with a low forecast of 23.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Privia Health Group Inc (PRVA)'s revenue for the last quarter?

Privia Health Group Inc revenue for the last quarter amounts to 580.42M USD, increased 32.54 % YoY.

arrow icon

What is Privia Health Group Inc (PRVA)'s earnings per share (EPS) for the last quarter?

Privia Health Group Inc. EPS for the last quarter amounts to 0.05 USD, increased 66.67 % YoY.

arrow icon

What changes have occurred in the market's expectations for Privia Health Group Inc (PRVA)'s fundamentals?

The market is revising Upward the revenue expectations for Privia Health Group, Inc. (PRVA) for FY2025, with the revenue forecasts being adjusted by 4.41% over the past three months. During the same period, the stock price has changed by 3.09%.
arrow icon

How many employees does Privia Health Group Inc (PRVA). have?

Privia Health Group Inc (PRVA) has 1140 emplpoyees as of December 05 2025.

arrow icon

What is Privia Health Group Inc (PRVA) market cap?

Today PRVA has the market capitalization of 2.95B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free